Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity

Velho, G. ; Hattersley, A. T. ; Froguel, P.
Springer
Published 2000
ISSN:
1432-0428
Keywords:
Keywords MODY ; glucokinase mutations ; low birth weight ; macrosomia ; gestational diabetes ; insulin secretion defect.
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Aims/hypothesis. Altered fetal insulin secretion caused by fetal or maternal glucokinase mutations influence birth weight. Here, we attempt to answer two additional questions: firstly, whether this variation in birth weight (from low birth weight to macrosomia) has an effect on adult height or weight. Secondly, whether maternal hyperglycaemia during fetal life has an effect on metabolic phenotypes of the adult offspring. Methods. We studied 447 family members from 37 MODY2 kindred, divided into four groups according to the presence or absence of a glucokinase mutation in the subject (S + or S–, respectively) and his/her mother (M + or M–). Birth weight data were obtained from a questionnaire sent to the mothers. Results. Birth weight was reduced in the presence of a fetal mutation (M–S + ) and increased in the presence of a maternal mutation (M + S–). These effects are additive as similar birth weights were observed in M + S + and M–S– offspring. Adult height, weight or body mass index (weight/height2) were, however, similar in the four groups of subjects. Non-diabetic adult offspring, regardless of the glycaemic status of the mothers (M + S– or M–S–), had similar insulin secretion, insulin sensitivity, blood pressures and lipid profiles. These variables as well as the severity of hyperglycaemia were similar in adult M + S + and M–S + MODY2 subjects. Conclusion/Interpretation. Maternal environment and fetal genotypes could alter growth in utero by changing fetal insulin secretion but these effects do not result in a persistent programming in latter life. [Diabetologia (2000) 43: 1060–1063]
Type of Medium:
Electronic Resource
URL:
_version_ 1798295382829039616
autor Velho, G.
Hattersley, A. T.
Froguel, P.
autorsonst Velho, G.
Hattersley, A. T.
Froguel, P.
book_url http://dx.doi.org/10.1007/s001250051490
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM199949999
issn 1432-0428
journal_name Diabetologia
materialart 1
notes Abstract Aims/hypothesis. Altered fetal insulin secretion caused by fetal or maternal glucokinase mutations influence birth weight. Here, we attempt to answer two additional questions: firstly, whether this variation in birth weight (from low birth weight to macrosomia) has an effect on adult height or weight. Secondly, whether maternal hyperglycaemia during fetal life has an effect on metabolic phenotypes of the adult offspring. Methods. We studied 447 family members from 37 MODY2 kindred, divided into four groups according to the presence or absence of a glucokinase mutation in the subject (S + or S–, respectively) and his/her mother (M + or M–). Birth weight data were obtained from a questionnaire sent to the mothers. Results. Birth weight was reduced in the presence of a fetal mutation (M–S + ) and increased in the presence of a maternal mutation (M + S–). These effects are additive as similar birth weights were observed in M + S + and M–S– offspring. Adult height, weight or body mass index (weight/height2) were, however, similar in the four groups of subjects. Non-diabetic adult offspring, regardless of the glycaemic status of the mothers (M + S– or M–S–), had similar insulin secretion, insulin sensitivity, blood pressures and lipid profiles. These variables as well as the severity of hyperglycaemia were similar in adult M + S + and M–S + MODY2 subjects. Conclusion/Interpretation. Maternal environment and fetal genotypes could alter growth in utero by changing fetal insulin secretion but these effects do not result in a persistent programming in latter life. [Diabetologia (2000) 43: 1060–1063]
package_name Springer
publikationsjahr_anzeige 2000
publikationsjahr_facette 2000
publikationsjahr_intervall 7999:2000-2004
publikationsjahr_sort 2000
publisher Springer
reference 43 (2000), S. 1060-1063
schlagwort Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
search_space articles
shingle_author_1 Velho, G.
Hattersley, A. T.
Froguel, P.
shingle_author_2 Velho, G.
Hattersley, A. T.
Froguel, P.
shingle_author_3 Velho, G.
Hattersley, A. T.
Froguel, P.
shingle_author_4 Velho, G.
Hattersley, A. T.
Froguel, P.
shingle_catch_all_1 Velho, G.
Hattersley, A. T.
Froguel, P.
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Abstract Aims/hypothesis. Altered fetal insulin secretion caused by fetal or maternal glucokinase mutations influence birth weight. Here, we attempt to answer two additional questions: firstly, whether this variation in birth weight (from low birth weight to macrosomia) has an effect on adult height or weight. Secondly, whether maternal hyperglycaemia during fetal life has an effect on metabolic phenotypes of the adult offspring. Methods. We studied 447 family members from 37 MODY2 kindred, divided into four groups according to the presence or absence of a glucokinase mutation in the subject (S + or S–, respectively) and his/her mother (M + or M–). Birth weight data were obtained from a questionnaire sent to the mothers. Results. Birth weight was reduced in the presence of a fetal mutation (M–S + ) and increased in the presence of a maternal mutation (M + S–). These effects are additive as similar birth weights were observed in M + S + and M–S– offspring. Adult height, weight or body mass index (weight/height2) were, however, similar in the four groups of subjects. Non-diabetic adult offspring, regardless of the glycaemic status of the mothers (M + S– or M–S–), had similar insulin secretion, insulin sensitivity, blood pressures and lipid profiles. These variables as well as the severity of hyperglycaemia were similar in adult M + S + and M–S + MODY2 subjects. Conclusion/Interpretation. Maternal environment and fetal genotypes could alter growth in utero by changing fetal insulin secretion but these effects do not result in a persistent programming in latter life. [Diabetologia (2000) 43: 1060–1063]
1432-0428
14320428
Springer
shingle_catch_all_2 Velho, G.
Hattersley, A. T.
Froguel, P.
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Abstract Aims/hypothesis. Altered fetal insulin secretion caused by fetal or maternal glucokinase mutations influence birth weight. Here, we attempt to answer two additional questions: firstly, whether this variation in birth weight (from low birth weight to macrosomia) has an effect on adult height or weight. Secondly, whether maternal hyperglycaemia during fetal life has an effect on metabolic phenotypes of the adult offspring. Methods. We studied 447 family members from 37 MODY2 kindred, divided into four groups according to the presence or absence of a glucokinase mutation in the subject (S + or S–, respectively) and his/her mother (M + or M–). Birth weight data were obtained from a questionnaire sent to the mothers. Results. Birth weight was reduced in the presence of a fetal mutation (M–S + ) and increased in the presence of a maternal mutation (M + S–). These effects are additive as similar birth weights were observed in M + S + and M–S– offspring. Adult height, weight or body mass index (weight/height2) were, however, similar in the four groups of subjects. Non-diabetic adult offspring, regardless of the glycaemic status of the mothers (M + S– or M–S–), had similar insulin secretion, insulin sensitivity, blood pressures and lipid profiles. These variables as well as the severity of hyperglycaemia were similar in adult M + S + and M–S + MODY2 subjects. Conclusion/Interpretation. Maternal environment and fetal genotypes could alter growth in utero by changing fetal insulin secretion but these effects do not result in a persistent programming in latter life. [Diabetologia (2000) 43: 1060–1063]
1432-0428
14320428
Springer
shingle_catch_all_3 Velho, G.
Hattersley, A. T.
Froguel, P.
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Abstract Aims/hypothesis. Altered fetal insulin secretion caused by fetal or maternal glucokinase mutations influence birth weight. Here, we attempt to answer two additional questions: firstly, whether this variation in birth weight (from low birth weight to macrosomia) has an effect on adult height or weight. Secondly, whether maternal hyperglycaemia during fetal life has an effect on metabolic phenotypes of the adult offspring. Methods. We studied 447 family members from 37 MODY2 kindred, divided into four groups according to the presence or absence of a glucokinase mutation in the subject (S + or S–, respectively) and his/her mother (M + or M–). Birth weight data were obtained from a questionnaire sent to the mothers. Results. Birth weight was reduced in the presence of a fetal mutation (M–S + ) and increased in the presence of a maternal mutation (M + S–). These effects are additive as similar birth weights were observed in M + S + and M–S– offspring. Adult height, weight or body mass index (weight/height2) were, however, similar in the four groups of subjects. Non-diabetic adult offspring, regardless of the glycaemic status of the mothers (M + S– or M–S–), had similar insulin secretion, insulin sensitivity, blood pressures and lipid profiles. These variables as well as the severity of hyperglycaemia were similar in adult M + S + and M–S + MODY2 subjects. Conclusion/Interpretation. Maternal environment and fetal genotypes could alter growth in utero by changing fetal insulin secretion but these effects do not result in a persistent programming in latter life. [Diabetologia (2000) 43: 1060–1063]
1432-0428
14320428
Springer
shingle_catch_all_4 Velho, G.
Hattersley, A. T.
Froguel, P.
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Keywords MODY
glucokinase mutations
low birth weight
macrosomia
gestational diabetes
insulin secretion defect.
Abstract Aims/hypothesis. Altered fetal insulin secretion caused by fetal or maternal glucokinase mutations influence birth weight. Here, we attempt to answer two additional questions: firstly, whether this variation in birth weight (from low birth weight to macrosomia) has an effect on adult height or weight. Secondly, whether maternal hyperglycaemia during fetal life has an effect on metabolic phenotypes of the adult offspring. Methods. We studied 447 family members from 37 MODY2 kindred, divided into four groups according to the presence or absence of a glucokinase mutation in the subject (S + or S–, respectively) and his/her mother (M + or M–). Birth weight data were obtained from a questionnaire sent to the mothers. Results. Birth weight was reduced in the presence of a fetal mutation (M–S + ) and increased in the presence of a maternal mutation (M + S–). These effects are additive as similar birth weights were observed in M + S + and M–S– offspring. Adult height, weight or body mass index (weight/height2) were, however, similar in the four groups of subjects. Non-diabetic adult offspring, regardless of the glycaemic status of the mothers (M + S– or M–S–), had similar insulin secretion, insulin sensitivity, blood pressures and lipid profiles. These variables as well as the severity of hyperglycaemia were similar in adult M + S + and M–S + MODY2 subjects. Conclusion/Interpretation. Maternal environment and fetal genotypes could alter growth in utero by changing fetal insulin secretion but these effects do not result in a persistent programming in latter life. [Diabetologia (2000) 43: 1060–1063]
1432-0428
14320428
Springer
shingle_title_1 Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
shingle_title_2 Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
shingle_title_3 Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
shingle_title_4 Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:35:18.978Z
titel Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
titel_suche Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity
topic WW-YZ
uid nat_lic_papers_NLM199949999